{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:38:05Z","timestamp":1788514685069,"version":"build-2803163510"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaad.2020.12.027","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T16:13:38Z","timestamp":1608653618000},"page":"587-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication"],"prefix":"10.1016","volume":"84","author":[{"given":"Joseph S.","family":"Durgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.12.027_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European Organization for\u00a0Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2020.12.027_bib3","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/toxins5081402","article-title":"Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma","volume":"5","author":"Willerslev-Olsen","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.jaad.2020.12.027_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2010.08.037","article-title":"S\u00e9zary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)","volume":"64","author":"Olsen","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2014-07-588236","article-title":"Lack of durable disease control with chemotherapy for mycosis fungoides and S\u00e9zary syndrome: a comparative study of systemic therapy","volume":"125","author":"Hughes","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI24826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2020.12.027_bib7","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.1992.03480100060031","article-title":"Infections complicating mycosis fungoides and S\u00e9zary syndrome","volume":"267","author":"Axelrod","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2020.12.027_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2008.08612.x","article-title":"Prevalence and treatment of staphylococcus aureus colonization in patients with mycosis fungoides and S\u00e9zary syndrome","volume":"159","author":"Talpur","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib9","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1158\/1078-0432.CCR-14-0707","article-title":"Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function","volume":"20","author":"Wolk","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1096\/fj.04-3284com","article-title":"Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1, 25-dihydroxyvitamin D3","volume":"19","author":"Gombart","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.jaad.2020.12.027_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaci.2008.08.020","article-title":"Administration of oral vitamin D induces cathelicidin production in atopic individuals","volume":"122","author":"Hata","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.12.027_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jaad.2007.06.025","article-title":"Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides","volume":"57","author":"Lee","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32.32_32_40","article-title":"Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1182\/blood-2015-08-662353","article-title":"Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma","volume":"127","author":"Willerslev-Olsen","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41408-020-0324-3","article-title":"Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in S\u00e9zary syndrome","volume":"10","author":"Willerslev-Olsen","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jaad.2020.12.027_bib16","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jaad.2020.12.027_bib17","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/IAI.01388-08","article-title":"Staphylococcus aureus superantigens elicit redundant and extensive human V beta patterns","volume":"77","author":"Thomas","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2020.12.027_bib18","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1182\/blood-2006-04-017863","article-title":"Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins","volume":"109","author":"Woetmann","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib19","doi-asserted-by":"crossref","first-page":"1751561","DOI":"10.1080\/2162402X.2020.1751561","article-title":"Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma","volume":"9","author":"Bl\u00fcmel","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaad.2020.12.027_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1995.tb02485.x","article-title":"Cutaneous colonization with staphylococci influences the disease activity of S\u00e9zary syndrome: a potential role for bacterial superantigens","volume":"133","author":"Tokura","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.2018888107","article-title":"Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma","volume":"134","author":"Lindahl","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib22","doi-asserted-by":"crossref","first-page":"75954","DOI":"10.18632\/oncotarget.12488","article-title":"Doxycycline is an NF-kapaB inhibitor that induces apoptotic cell death in malignant T-cells","volume":"7","author":"Alexander-Savino","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaad.2020.12.027_bib23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00126334-200408150-00004","article-title":"T-cell lymphoma in HIV-infected patients","volume":"36","author":"Arzoo","year":"2004","journal-title":"Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaad.2020.12.027_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jaad.2009.11.692","article-title":"Infectious agents in cutaneous T-cell lymphoma","volume":"64","author":"Mirvish","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaad.2005.10.015","article-title":"Primary cutaneous T-cell lymphoma occurring after organ transplantation","volume":"54","author":"Ravat","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib26","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2017.12.068","article-title":"Progression of undiagnosed cutaneous lymphoma after anti\u2013tumor necrosis factor-alpha therapy","volume":"78","author":"Martinez-Escala","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mjd.2002.120571","article-title":"Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine","volume":"47","author":"Zackheim","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: case review of 7 patients","volume":"83","author":"Espinosa","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib29","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8 T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, fas ligand, and killing inhibitory receptors and their relationship with clinical behavior","volume":"19","author":"Vermeer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2020.12.027_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/1523-1747.ep12292129","article-title":"Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma","volume":"108","author":"Asadullah","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1998.00599.x","article-title":"Tumour-specific cytotoxic T lymphocyte activity in Th2-type S\u00e9zary syndrome: its enhancement by interferon-gamma (IFN-\u03b3) and IL-12 and fluctuations in association with disease activity","volume":"112","author":"Seo","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2020.12.027_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12388985","article-title":"Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas S\u00e9zary syndrome express a Th2-type profile","volume":"103","author":"Saed","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib33","doi-asserted-by":"crossref","first-page":"e124233","DOI":"10.1172\/jci.insight.124233","article-title":"Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma","volume":"4","author":"Vieyra-Garcia","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaad.2020.12.027_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1523-1747.ep12363378","article-title":"The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens","volume":"107","author":"Berger","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib35","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.171.5.2714","article-title":"Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma","volume":"171","author":"Winter","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2020.12.027_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by S\u00e9zary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib38","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","article-title":"TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma","volume":"19","author":"Guenova","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib39","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood.V99.3.973","article-title":"Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3","volume":"99","author":"Nielsen","year":"2002","journal-title":"Blood"},{"issue":"suppl","key":"10.1016\/j.jaad.2020.12.027_bib40","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1007\/PL00014051","article-title":"The critical role of Th1-dominant immunity in tumor immunology","volume":"46","author":"Nishimura","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaad.2020.12.027_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1523-1747.2000.00995.x","article-title":"Cutaneous T cell lymphoma reactive CD4 cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis","volume":"115","author":"Echchakir","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib42","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.18632\/oncotarget.23334","article-title":"Chronic activation profile of circulating CD8 T cells in S\u00e9zary syndrome","volume":"9","author":"Torrealba","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaad.2020.12.027_bib43","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/2326-6066.CIR-17-0270","article-title":"Primary T cells from cutaneous T-cell lymphoma skin explants display an exhausted immune checkpoint profile","volume":"6","author":"Querfeld","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib44","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.0022-202X.2005.23914.x","article-title":"Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in S\u00e9zary syndrome patients","volume":"125","author":"Bouaziz","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib45","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archdermatol.2010.200","article-title":"Increased programmed death-1 expression on CD4 T cells in cutaneous T-cell lymphoma: implications for immune suppression","volume":"146","author":"Samimi","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jid.2016.08.016","article-title":"TIGIT and helios are highly expressed on CD4 T cells in S\u00e9zary syndrome patients","volume":"137","author":"Jariwala","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.jid.5700029","article-title":"Increased expression of CTLA-4 in malignant T cells from patients with mycosis fungoides cutaneous T-cell lymphoma","volume":"126","author":"Wong","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib48","first-page":"4430","article-title":"Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies","volume":"54","author":"Tendler","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1158\/2326-6066.CIR-15-0303","article-title":"Effector regulatory T cells reflect the equilibrium between antitumor immunity and autoimmunity in adult T-cell leukemia","volume":"4","author":"Ureshino","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2326-6066.CIR-15-0148","article-title":"Hypomethylation of the Treg-specific demethylated region in FOXP3 is a hallmark of the regulatory T-cell subtype in adult T-cell leukemia","volume":"4","author":"Shimazu","year":"2016","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib51","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","article-title":"S\u00e9zary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines","volume":"100","author":"Wysocka","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib52","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib53","first-page":"921","article-title":"Functional and phenotypical alterations of polymorphonuclear cells in S\u00e9zary syndrome patients","volume":"21","author":"Fierro","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib54","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2003-04-1044","article-title":"Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma","volume":"102","author":"Yawalkar","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00403-009-1023-x","article-title":"Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma","volume":"302","author":"Yamanaka","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1067\/mjd.2001.116345","article-title":"Complete molecular remission during biologic response modifier therapy for S\u00e9zary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity","volume":"45","author":"Yoo","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib57","doi-asserted-by":"crossref","first-page":"74592","DOI":"10.18632\/oncotarget.12816","article-title":"Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in S\u00e9zary syndrome","volume":"7","author":"Manfrere","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaad.2020.12.027_bib58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2567.1997.00325.x","article-title":"Extracorporeal photochemotherapy restores Th1\/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma","volume":"92","author":"Di Renzo","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.jaad.2020.12.027_bib59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0190-9622(96)90605-2","article-title":"Detection of circulating T cells with CD4+CD7\u2212 immunophenotype in patients with benign and malignant lymphoproliferative dermatoses","volume":"35","author":"Harmon","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0190-9622(90)70080-2","article-title":"Leu-8\/CD7 antigen expression by CD3 T cells: comparative analysis of skin and blood in mycosis fungoides\/S\u00e9zary syndrome relative to normal blood values","volume":"22","author":"Wood","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib61","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood","volume":"115","author":"Jones","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2020.12.027_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+CD26\u2212 subset in the identification of circulating S\u00e9zary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1523-1747.ep12389114","article-title":"Detection of clonal T-cell receptor beta gene rearrangements in early mycosis fungoides\/S\u00e9zary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR\/DGGE)","volume":"103","author":"Wood","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib64","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/modpathol.2009.175","article-title":"Flow cytometric detection of peripheral blood involvement by mycosis fungoides and S\u00e9zary syndrome using T-cell receptor V beta chain antibodies and its application in blood staging","volume":"23","author":"Feng","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2020.12.027_bib65","doi-asserted-by":"crossref","first-page":"214ra171","DOI":"10.1126\/scitranslmed.3007420","article-title":"Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma","volume":"5","author":"Weng","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaad.2020.12.027_bib66","doi-asserted-by":"crossref","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaad.2020.12.027_bib67","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with S\u00e9zary syndrome","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2001.tb03710.x","article-title":"Reversible resistance to apoptosis in cutaneous T cell lymphoma","volume":"941","author":"Meech","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2020.12.027_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","article-title":"Activation induced cell death in T cells","volume":"193","author":"Green","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaad.2020.12.027_bib71","first-page":"2682","article-title":"Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8 cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?","volume":"7","author":"Ni","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib72","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma","volume":"62","author":"van Doorn","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib73","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Dereure","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib74","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-08-4631","article-title":"Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death","volume":"69","author":"Klemke","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib75","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","article-title":"Constitutive expression of NF-\u03baB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis","volume":"31","author":"Izban","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2020.12.027_bib76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdermsci.2017.11.019","article-title":"PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21","volume":"90","author":"Wang","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2020.12.027_bib77","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In\u00a0vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jaad.2020.12.027_bib78","doi-asserted-by":"crossref","first-page":"e24849","DOI":"10.1371\/journal.pone.0024849","article-title":"Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells","volume":"6","author":"Marzec","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2020.12.027_bib79","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.V92.1.252.413k08_252_258","article-title":"Interleukin-15 is an autocrine\/paracrine viability factor for cutaneous T-cell lymphoma cells","volume":"92","author":"D\u00f6bbeling","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/1541-7786.MCR-19-0894","article-title":"The Th9 axis reduces the oxidative stress and promotes the survival of malignant T cells in cutaneous T-cell lymphoma patients","volume":"18","author":"Kumar","year":"2020","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jaad.2020.12.027_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.it.2014.04.002","article-title":"GATA3: a master of many trades in immune regulation","volume":"35","author":"Wan","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaad.2020.12.027_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20021200","article-title":"The Runx1 transcription factor inhibits the differentiation of naive CD4 T cells into the Th2 lineage by repressing GATA3 expression","volume":"198","author":"Komine","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2020.12.027_bib83","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/icb.2009.114","article-title":"Transcriptional regulation of Th2 cell differentiation","volume":"88","author":"Zhu","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaad.2020.12.027_bib84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.immuni.2010.12.013","article-title":"The transcription factor STAT3 is required for T helper 2 cell development","volume":"34","author":"Stritesky","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaad.2020.12.027_bib85","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4161\/15384101.2014.947759","article-title":"Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines","volume":"13","author":"Litvinov","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jaad.2020.12.027_bib86","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jaad.2020.12.027_bib87","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of S\u00e9zary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2020.12.027_bib88","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2020.12.027_bib89","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood-2009-04-216671","article-title":"B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib90","doi-asserted-by":"crossref","first-page":"1738797","DOI":"10.1080\/2162402X.2020.1738797","article-title":"Blockade of programmed cell death protein 1 (PD-1) in s\u00e9zary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation","volume":"9","author":"Saulite","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jaad.2020.12.027_bib91","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/DAD.0b013e31821c35cb","article-title":"Expression patterns of the immunosuppressive proteins PD-1\/CD279 and PD-L1\/CD274 at different stages of cutaneous T-cell lymphoma (CTCL)\/mycosis fungoides (MF)","volume":"34","author":"Kantekure","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2020.12.027_bib92","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/jid.2012.265","article-title":"Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for S\u00e9zary syndrome","volume":"133","author":"Gibson","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib93","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1182\/bloodadvances.2018030577","article-title":"Targeting CD47 in S\u00e9zary syndrome with SIRP\u03b1Fc","volume":"3","author":"Johnson","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaad.2020.12.027_bib94","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00262-006-0239-2","article-title":"Immuno-screening of a cutaneous T-cell lymphoma library for plasma membrane proteins","volume":"56","author":"Lee","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaad.2020.12.027_bib95","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ijc.10967","article-title":"Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity","volume":"104","author":"Eichm\u00fcller","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2020.12.027_bib96","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1523-1747.2003.12318.x","article-title":"cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing","volume":"121","author":"Koch","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib97","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/CCO.0000000000000243","article-title":"Tumor microenvironment in mycosis fungoides and S\u00e9zary syndrome","volume":"28","author":"Gonzalez","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jaad.2020.12.027_bib98","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1158\/1535-7163.MCT-12-0278","article-title":"Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cells","volume":"11","author":"Chang","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaad.2020.12.027_bib99","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of S\u00e9zary\u00a0cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.2013.279","article-title":"CD164 and FCRL3 are highly expressed on CD4 CD26\u2212 T cells in S\u00e9zary syndrome patients","volume":"134","author":"Wysocka","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib101","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1182\/blood-2010-08-302034","article-title":"S\u00e9zary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-\u03b2 on the cell surface","volume":"117","author":"Chung","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib102","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4049\/jimmunol.176.1.652","article-title":"SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of S\u00e9zary cells","volume":"176","author":"Huet","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2020.12.027_bib103","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib104","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/sj.jid.5700121","article-title":"A role for regulatory T cells in cutaneous T-cell lymphoma; induction of a CD4+ CD25+ Foxp3+ T cell phenotype associated with HTLV-I infection","volume":"126","author":"Walsh","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib105","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/jid.2013.227","article-title":"IL-31 is produced by the malignant T-cell population in cutaneous T-cell lymphoma and correlates with CTCL pruritus","volume":"133","author":"Singer","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2015.02.014","article-title":"Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities","volume":"158","author":"Cedeno-Laurent","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2020.12.027_bib107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.dsi.2012.08.004","article-title":"Pathophysiology of chemokines and chemokine receptors in dermatological science: a focus on psoriasis and cutaneous T-cell lymphoma","volume":"30","author":"Lee","year":"2012","journal-title":"Dermatologica Sinica"},{"key":"10.1016\/j.jaad.2020.12.027_bib108","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2007-06-095182","article-title":"IL-2\u2013and IL-15\u2013induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4 T lymphocytes","volume":"111","author":"Marzec","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib109","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1182\/blood-2005-03-1139","article-title":"Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma","volume":"107","author":"Yamanaka","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib110","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib111","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","article-title":"The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2020.12.027_bib112","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1365-2133.2003.05674.x","article-title":"Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy","volume":"149","author":"Thumann","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.12.027_bib113","first-page":"105","article-title":"Interferon gamma stimulates cellular maturation of dendritic cell line DC2. 4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity","volume":"4","author":"He","year":"2007","journal-title":"Cell Mol Immunol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222033187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222033187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:00Z","timestamp":1759273080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222033187X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S019096222033187X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.12.027","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradication","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(21)00117-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}